Clinical significance of non-invasive in vitro drug sensitivity profiling using pancreatic cancer organoids derived from saline flushes collected during routine EUS-FNA.
Saved in:
| Title: | Clinical significance of non-invasive in vitro drug sensitivity profiling using pancreatic cancer organoids derived from saline flushes collected during routine EUS-FNA. |
|---|---|
| Authors: | Ekawa T; Department of Cancer Drug Discovery and Development, Research Centre, Osaka International Cancer Institute, Osaka, Japan. tomoya.ekawa@oici.jp.; Department of Cancer Immunotherapy, Research Centre, Osaka International Cancer Institute, Osaka, Japan. tomoya.ekawa@oici.jp., Ikezawa K; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan., Kukita Y; Laboratory of Genomic Pathology, Research Centre, Osaka International Cancer Institute, Osaka, Japan., Urabe M; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan., Kai Y; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan., Takada R; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan., Akazawa T; Department of Cancer Drug Discovery and Development, Research Centre, Osaka International Cancer Institute, Osaka, Japan.; Department of Cancer Immunotherapy, Research Centre, Osaka International Cancer Institute, Osaka, Japan., Mizote Y; Department of Cancer Drug Discovery and Development, Research Centre, Osaka International Cancer Institute, Osaka, Japan.; Department of Cancer Immunotherapy, Research Centre, Osaka International Cancer Institute, Osaka, Japan., Tatsumi K; Department of Cancer Drug Discovery and Development, Research Centre, Osaka International Cancer Institute, Osaka, Japan.; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Medical Development, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan., Nagata S; Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan., Ogawa H; Nitto Joint Research Department for Nucleic Acid Medicine, Research Centre, Osaka International Cancer Institute, Osaka, Japan., Hasegawa S; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Takahashi H; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Ohkawa K; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan., Tahara H; Department of Cancer Drug Discovery and Development, Research Centre, Osaka International Cancer Institute, Osaka, Japan.; Centre for Clinical Research, Osaka International Cancer Institute, Osaka, Japan. |
| Source: | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2026 May; Vol. 28 (5), pp. 1940-1946. Date of Electronic Publication: 2025 Nov 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41269488 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical significance of non-invasive in vitro drug sensitivity profiling using pancreatic cancer organoids derived from saline flushes collected during routine EUS-FNA. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ekawa+T%22">Ekawa T</searchLink>; Department of Cancer Drug Discovery and Development, Research Centre, Osaka International Cancer Institute, Osaka, Japan. tomoya.ekawa@oici.jp.; Department of Cancer Immunotherapy, Research Centre, Osaka International Cancer Institute, Osaka, Japan. tomoya.ekawa@oici.jp.<br /><searchLink fieldCode="AU" term="%22Ikezawa+K%22">Ikezawa K</searchLink>; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Kukita+Y%22">Kukita Y</searchLink>; Laboratory of Genomic Pathology, Research Centre, Osaka International Cancer Institute, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Urabe+M%22">Urabe M</searchLink>; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Kai+Y%22">Kai Y</searchLink>; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Takada+R%22">Takada R</searchLink>; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Akazawa+T%22">Akazawa T</searchLink>; Department of Cancer Drug Discovery and Development, Research Centre, Osaka International Cancer Institute, Osaka, Japan.; Department of Cancer Immunotherapy, Research Centre, Osaka International Cancer Institute, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Mizote+Y%22">Mizote Y</searchLink>; Department of Cancer Drug Discovery and Development, Research Centre, Osaka International Cancer Institute, Osaka, Japan.; Department of Cancer Immunotherapy, Research Centre, Osaka International Cancer Institute, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Tatsumi+K%22">Tatsumi K</searchLink>; Department of Cancer Drug Discovery and Development, Research Centre, Osaka International Cancer Institute, Osaka, Japan.; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Medical Development, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Nagata+S%22">Nagata S</searchLink>; Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Ogawa+H%22">Ogawa H</searchLink>; Nitto Joint Research Department for Nucleic Acid Medicine, Research Centre, Osaka International Cancer Institute, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Hasegawa+S%22">Hasegawa S</searchLink>; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Takahashi+H%22">Takahashi H</searchLink>; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Ohkawa+K%22">Ohkawa K</searchLink>; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Tahara+H%22">Tahara H</searchLink>; Department of Cancer Drug Discovery and Development, Research Centre, Osaka International Cancer Institute, Osaka, Japan.; Centre for Clinical Research, Osaka International Cancer Institute, Osaka, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101247119%22">Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico</searchLink> [Clin Transl Oncol] 2026 May; Vol. 28 (5), pp. 1940-1946. <i>Date of Electronic Publication: </i>2025 Nov 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Italia%22">Springer Italia </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>101247119 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1699-3055 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221699048X%22">1699048X </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41269488 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12094-025-04111-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1940 Titles: – TitleFull: Clinical significance of non-invasive in vitro drug sensitivity profiling using pancreatic cancer organoids derived from saline flushes collected during routine EUS-FNA. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ekawa T – PersonEntity: Name: NameFull: Ikezawa K – PersonEntity: Name: NameFull: Kukita Y – PersonEntity: Name: NameFull: Urabe M – PersonEntity: Name: NameFull: Kai Y – PersonEntity: Name: NameFull: Takada R – PersonEntity: Name: NameFull: Akazawa T – PersonEntity: Name: NameFull: Mizote Y – PersonEntity: Name: NameFull: Tatsumi K – PersonEntity: Name: NameFull: Nagata S – PersonEntity: Name: NameFull: Ogawa H – PersonEntity: Name: NameFull: Hasegawa S – PersonEntity: Name: NameFull: Takahashi H – PersonEntity: Name: NameFull: Ohkawa K – PersonEntity: Name: NameFull: Tahara H IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1699-3055 Numbering: – Type: volume Value: 28 – Type: issue Value: 5 Titles: – TitleFull: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico Type: main |
| ResultId | 1 |
